Skip to main content

Table 3 Governments in the WHO European Region reporting activities addressing viral hepatitis by WHO Global Hepatitis Programme strategic axis (N=44)

From: Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey

   N=44 n (%) Member States Reporting Activities
National Coordination Have viral hepatitis programme activities targeting PWID as a specific population 32 (73) Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Ireland, Israel, Italy, Kyrgyzstan, Latvia, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom
  Have a written national viral hepatitis prevention and control strategy or plan which includes a component relating to injection drug use 12 (27) Armenia, Austria, Czech Republic, Denmark, France, Israel, Kyrgyzstan, Republic of Moldova, Russian Federation, Slovenia, Turkey, United Kingdom
Axis 1 Held events for World Hepatitis Day 2012 17 (39) Albania, Armenia, Azerbaijan, Belarus, Bulgaria, Croatia, France, Georgia, Italy, Latvia, Lithuania, Malta, Netherlands, Republic of Moldova, Russian Federation , Slovenia, Sweden
  Funded viral hepatitis awareness campaigns focusing on harm reduction for PWID (other than World Hepatitis Day) 10 (23) Armenia, Belarus, Croatia, Netherlands, Republic of Moldova, Russian Federation, Slovenia, Sweden, Turkey, United Kingdom
Axis 2 Conduct regular serosurveys among PWID 12 (27) Belarus, Croatia, Denmark, Finland, France, Montenegro, Moldova, Russian Federation, Slovenia, Tajikistan, Ukraine, United Kingdom
Axis 3 Have a national policy for prevention of viral hepatitis among PWID 25 (53) Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Israel, Italy, Kyrgyzstan, Luxembourg, Netherlands, Poland, Republic of Moldova, Russian Federation, Slovenia, Spain, Sweden, Switzerland, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom, Uzbekistan
Axis 4 Have HBV and HCV testing which is:   
  • Free of charge for all individuals 20 (45) • Albania, Austria, Azerbaijan, Belarus, Belgium, Croatia, Denmark, Finland, France, Germany, Israel, Italy, Montenegro, Republic of Moldova, Malta, San Marino, Slovakia, Spain, Sweden, United Kingdom
  • Free of charge for PWID 6 (14) • Bulgaria, Czech Republic, Latvia, Slovenia Turkey, The Former Yugoslav Republic of Macedonia
  Have publicly funded treatment for HBV 36 (82) Andorra, Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom
  Have publicly funded treatment for HCV 35 (80) Andorra, Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovenia, Spain, Sweden, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom